MedTrace Logo

Risk-based Screen and Prognostic Analysis for Second Primary Malignancies in Kidney Cancer Patients

NCT06531629 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 72408

Last updated 2024-08-06

No results posted yet for this study

Summary

Second primary malignancy (SPM) significantly impacts the survival and prognosis of patients. This study endeavors to identify risk and prognostic factors associated with SPM after first primary kidney cancer and construct predictive nomograms.

Conditions

Interventions

PROCEDURE

Surgery, radiation therapy and chemotherapy

Surgery, radiation therapy and chemotherapy

Sponsors & Collaborators

  • Peking University First Hospital

    lead OTHER

Principal Investigators

  • Kan Gong · Peking University First Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06531629 on ClinicalTrials.gov